An interventional study of Food advertisements and Tech advertisements in GLP - 1, sponsored by Penn State University. Not yet recruiting. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by Penn State University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this randomized control trial is to compare how food cravings, food selection, and food consumption change in response to frequent food advertisements compared to non-food advertisements in adults taking GLP-1 (weight loss) medications. The primary question we aim to answer is: do GLP-1 medications reduce an individual's vulnerability to external triggers that drive food cravings and consumption?
Participants will:
Penn State University is the lead sponsor of 271 studies on the registry; 54 are open to participants now.
Of its 15 completed or terminated interventional studies of FDA-regulated products, 11 (73%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Advertisements viewed daily by this group will be food and/or beverage products
Behavioral: Food advertisements
Individuals in this group will only receive tech-related advertisements daily
Behavioral: Tech advertisements
Videos and images of food and beverage advertisements from popular brands and/or restaurants
Video and photo advertisements of popular tech tools
Mean food cue reactivity scores in the afternoon
Average scores of craving levels for each group following afternoon advertisement viewing sessions
Time frame: 7-day period of all afternoon survey responses
Mean food cue reactivity scores in the morning
Average scores of craving levels for each group following morning advertisement viewing sessions
Time frame: 7-day period of all morning survey responses
Mean food cue reactivity scores in the evening
Average scores of craving levels for each group following evening advertisement viewing sessions
Time frame: 7-day period of all evening survey responses
Mean food cue reactivity scores overall
Average scores of craving levels for each group over all viewing sessions
Time frame: 7-day period of all survey responses
Energy density of consumed foods
The energy density profile of foods consumed each day
Time frame: 7 days
Change from baseline in energy density of foods selected in the virtual buffet
Time frame: Baseline and 7 days
Changes in food noise since being on medication questionnaire
Questionnaire assessing various aspects of food noise at present compared to before the medication
Time frame: Baseline
Changes in reasons for purchasing foods questionnaire
A questionnaire that assesses how five factors impact purchasing choices, and how the main factors have changed between prior to starting the medication and after.
Time frame: Baseline
Individual Food Cue Responsiveness--Trait
Time frame: Baseline
Change in brand familiarity, liking, and/or craving
A questionnaire that measures the familiarity, liking, and craving of each brand the participant will be exposed to (baseline) or has been exposed to (after intervention).
Time frame: Baseline and 7 days
No study locations are listed for this record.
Start is estimated for Sep 2026; primary completion for Dec 2026, 3 months later.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 7, 2026: start May 2026 → Sep 2026, primary completion Aug 2026 → Dec 2026 and completion Sep 2026 → Dec 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.